CY2193B1 - Combination of atovaquone with proguanil for the treatment of protozoal infections - Google Patents

Combination of atovaquone with proguanil for the treatment of protozoal infections

Info

Publication number
CY2193B1
CY2193B1 CY0000044A CY0000044A CY2193B1 CY 2193 B1 CY2193 B1 CY 2193B1 CY 0000044 A CY0000044 A CY 0000044A CY 0000044 A CY0000044 A CY 0000044A CY 2193 B1 CY2193 B1 CY 2193B1
Authority
CY
Cyprus
Prior art keywords
proguanil
atovaquone
treatment
combination
protozoal infections
Prior art date
Application number
CY0000044A
Other languages
English (en)
Inventor
Winston Edward Gutteridge
David Brian Ashton Hutchinson
Victoria Susan Latter
Mary Pudney
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10725687&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY2193(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of CY2193B1 publication Critical patent/CY2193B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CY0000044A 1992-11-26 2000-08-29 Combination of atovaquone with proguanil for the treatment of protozoal infections CY2193B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929224739A GB9224739D0 (en) 1992-11-26 1992-11-26 Medicaments

Publications (1)

Publication Number Publication Date
CY2193B1 true CY2193B1 (en) 2002-11-08

Family

ID=10725687

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0000044A CY2193B1 (en) 1992-11-26 2000-08-29 Combination of atovaquone with proguanil for the treatment of protozoal infections

Country Status (38)

Country Link
US (3) US5998449A (no)
EP (1) EP0670719B1 (no)
JP (1) JP3768231B2 (no)
KR (1) KR100294802B1 (no)
CN (1) CN1087935C (no)
AP (1) AP517A (no)
AT (1) ATE191340T1 (no)
AU (1) AU685408B2 (no)
BG (1) BG62595B1 (no)
CA (1) CA2150234E (no)
CY (1) CY2193B1 (no)
CZ (2) CZ289171B6 (no)
DE (1) DE69328307T2 (no)
DK (1) DK0670719T3 (no)
ES (1) ES2145114T3 (no)
GB (1) GB9224739D0 (no)
GR (1) GR3033745T3 (no)
HK (1) HK1004468A1 (no)
HU (1) HU225918B1 (no)
IL (1) IL107755A (no)
MX (1) MX9307402A (no)
MY (1) MY114241A (no)
NO (1) NO313225B1 (no)
NZ (1) NZ257901A (no)
OA (1) OA10352A (no)
PE (1) PE55694A1 (no)
PL (1) PL174323B1 (no)
PT (1) PT670719E (no)
RO (1) RO119280B1 (no)
RU (1) RU2108092C1 (no)
SA (1) SA93140434B1 (no)
SG (1) SG45387A1 (no)
SI (1) SI9300614A (no)
SK (1) SK281559B6 (no)
TW (1) TW253835B (no)
UA (1) UA45948C2 (no)
WO (1) WO1994012164A1 (no)
ZA (1) ZA938832B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
GB9424013D0 (en) * 1994-11-29 1995-01-18 Wellcome Found Medicaments
DE19737463A1 (de) * 1997-08-28 1999-03-04 Hoechst Marion Roussel De Gmbh Verwendung von Inhibitoren des Natrium-Wasserstoff-Austauschers zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen, die durch Protozoen verursacht werden
GB9822681D0 (en) * 1998-10-16 1998-12-09 Vitabiotics Ltd Method of treatment
CZ294903B6 (cs) * 1999-04-09 2005-04-13 Glaxo Group Limited Kombinační prostředek pro léčení malárie
US7104076B2 (en) * 2004-06-24 2006-09-12 Carrier Corporation Lubricant return schemes for use in refrigerant cycle
ITMI20070941A1 (it) * 2007-05-09 2008-11-10 Chimico Internazi0Nale S P A L Procedimento per la preparazione di naftochinoni trans2,3-disostituiti
ES2517366T3 (es) * 2009-08-20 2014-11-03 Ipca Laboratories Limited Nuevo complejo para el tratamiento y/o profilaxis de infecciones parasitarias
US20180055835A1 (en) 2016-08-25 2018-03-01 Immune Therapeutics Inc. Method for Treating And Preventing Protozoal Infections

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2533648A (en) * 1949-03-05 1950-12-12 Joseph H Warburg Circular saw making
NL6411993A (no) * 1963-10-18 1965-04-20
US3347830A (en) * 1964-07-30 1967-10-17 Grace W R & Co Process of polymerizing formaldehyde
GB1141735A (en) * 1966-11-23 1969-01-29 Pfizer & Co C Pharmaceutical anti-tumor composition
NL6817526A (no) * 1968-01-24 1969-07-28
US3655699A (en) * 1970-03-02 1972-04-11 Pfizer Analogues of lapachol as antitumor agents
DE2601458A1 (de) * 1975-01-20 1976-07-22 Ciba Geigy Ag Loesliche, von phenylindandiaminen abgeleitete polyamide
JPS5492945A (en) * 1977-11-22 1979-07-23 Wellcome Found Naphthoquinone derivative
US4485117A (en) * 1981-10-16 1984-11-27 Hudson Alan T Antiprotozoal compounds
US4485116A (en) * 1981-10-16 1984-11-27 Hudson Alan T Antiprotozoal compounds
GB8310141D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Naphthoquinone derivatives
GB8310140D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Antiprotozoal agents
US5053432A (en) * 1983-04-14 1991-10-01 Burroughs Wellcome Co. Naphthoquinone derivatives
JPS59196467A (ja) * 1983-04-23 1984-11-07 Nissan Motor Co Ltd 車輪速及びまたは車輪加減速度検出方法
US5225184A (en) * 1988-08-16 1993-07-06 Burroughs Wellcome Co. Medicaments
GB8819477D0 (en) * 1988-08-16 1988-09-21 Wellcome Found Medicaments
US5206268A (en) * 1988-08-16 1993-04-27 Burroughs Wellcome Co. Medicaments
JP2804302B2 (ja) * 1988-08-16 1998-09-24 ザ ウエルカム フアウンデーション リミテッド 治療剤
GB8921516D0 (en) * 1989-09-22 1989-11-08 Wellcome Found Medicaments
GB8923254D0 (en) * 1989-10-16 1989-12-06 Wellcome Found Medicaments
US5014737A (en) * 1989-11-13 1991-05-14 Allan Berman Quartz integrated trough/sump recirculating filtered high-purity chemical bath
GB9121316D0 (en) * 1991-10-09 1991-11-20 Wellcome Found Heterocyclic compounds
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
GB9226905D0 (en) * 1992-12-24 1993-02-17 Wellcome Found Pharmaceutical preparation
ES2095772T3 (es) * 1993-05-05 1997-02-16 Palo Alto Medical Found Utilizacion de derivados de rifamicina para producir un medicamento destinado al tratamiento de la toxoplasmosis.
US5529994A (en) * 1993-05-05 1996-06-25 Palo Alto Medical Foundation Treatment for toxoplasmosis
US5733932A (en) * 1995-01-06 1998-03-31 The Picower Institute For Medical Research Compounds and methods of use to derivatize neighboring lysine residues in proteins under physiological conditions
US5744168A (en) * 1995-12-07 1998-04-28 The Procter & Gamble Company Methods and compositions for the prevention and treatment of gastrointestinal disorders
US5827543A (en) * 1995-12-07 1998-10-27 The Procter & Gamble Company Methods and compositions for the prevention and treatment of urogenital disorders
US5747476A (en) * 1996-07-17 1998-05-05 Mortar & Pestle Veterinary Pharmacy, Inc. Treatment of equine protozoal myeloencephalitis
ZA983331B (en) * 1997-05-01 1998-10-27 Allegheny University Of The He Method for treating protozoal infections
AUPO821097A0 (en) * 1997-07-25 1997-08-14 Cultor Ltd. A prophylactic
DE19737463A1 (de) * 1997-08-28 1999-03-04 Hoechst Marion Roussel De Gmbh Verwendung von Inhibitoren des Natrium-Wasserstoff-Austauschers zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen, die durch Protozoen verursacht werden
CZ294903B6 (cs) * 1999-04-09 2005-04-13 Glaxo Group Limited Kombinační prostředek pro léčení malárie

Also Published As

Publication number Publication date
AU685408B2 (en) 1998-01-22
RO119280B1 (ro) 2004-07-30
CN1091632A (zh) 1994-09-07
BG99656A (bg) 1996-04-30
CN1087935C (zh) 2002-07-24
OA10352A (en) 2001-10-22
JPH08503938A (ja) 1996-04-30
NO313225B1 (no) 2002-09-02
TW253835B (no) 1995-08-11
IL107755A0 (en) 1994-02-27
PL174323B1 (pl) 1998-07-31
ES2145114T3 (es) 2000-07-01
ZA938832B (en) 1995-05-25
UA45948C2 (uk) 2002-05-15
AU5532294A (en) 1994-06-22
DE69328307D1 (de) 2000-05-11
NZ257901A (en) 1997-01-29
MY114241A (en) 2002-09-30
CZ289692B6 (cs) 2002-03-13
CZ119295A3 (en) 1995-11-15
SI9300614A (en) 1994-06-30
IL107755A (en) 2000-10-31
SK281559B6 (sk) 2001-05-10
HK1004468A1 (en) 1998-11-27
BG62595B1 (bg) 2000-03-31
MX9307402A (es) 1994-07-29
EP0670719A1 (en) 1995-09-13
SK57095A3 (en) 1996-05-08
AP517A (en) 1996-08-23
HU9501537D0 (en) 1995-07-28
US6166046A (en) 2000-12-26
NO951995D0 (no) 1995-05-19
CZ289171B6 (cs) 2001-11-14
PL309222A1 (en) 1995-10-02
GR3033745T3 (en) 2000-10-31
US5998449A (en) 1999-12-07
EP0670719B1 (en) 2000-04-05
RU2108092C1 (ru) 1998-04-10
ATE191340T1 (de) 2000-04-15
JP3768231B2 (ja) 2006-04-19
HU225918B1 (en) 2007-12-28
US6291488B1 (en) 2001-09-18
HUT71346A (en) 1995-11-28
CA2150234C (en) 2001-01-16
DK0670719T3 (da) 2000-07-31
NO951995L (no) 1995-07-03
SA93140434B1 (ar) 2004-09-01
GB9224739D0 (en) 1993-01-13
DE69328307T2 (de) 2000-10-26
CA2150234E (en) 2005-03-22
PT670719E (pt) 2000-09-29
CA2150234A1 (en) 1994-06-09
KR100294802B1 (ko) 2001-09-17
WO1994012164A1 (en) 1994-06-09
PE55694A1 (es) 1995-01-25
AP9300592A0 (en) 1994-01-31
SG45387A1 (en) 1998-01-16

Similar Documents

Publication Publication Date Title
HUT64764A (en) Carbapenem-derivatives with antibiotic effect and medical preparatives containing them and process for the production thereof
ZA9410036B (en) Methods for the treatment of prevention of conditions associated with amyloidogenic peptides
HK1004468A1 (en) Combination of atovaquone with proguanil for the treatment of protozoal infections
AU4444993A (en) Heat treatment
GB9203039D0 (en) Treatment
GB9226958D0 (en) Produktionsaktieselskab) novel treatment
AU6130194A (en) 1,2-dithiole-3-thiones for the treatment of reverse transcriptase-dependent viral infections
EP0441475A3 (en) Baquiloprim for treating protozoal infections
ZA93348B (en) Treatment of liquids.
GB9325111D0 (en) Slingshot body
GB2273829B (en) Lampholder
GB9219507D0 (en) The levering laryngoscope
CA70929S (en) Coverd canister or the like
GB9224468D0 (en) Fluid treatment system
GB9304905D0 (en) Processes
GB9200981D0 (en) The neutralizer
ZA94566B (en) Pinch cock
CA70930S (en) Canister or the like
GB9316515D0 (en) Treatment tubes
GB9322965D0 (en) The body
GB9206395D0 (en) Treatment
GB9203249D0 (en) Treatment
GB9200360D0 (en) Treatment
GB9200361D0 (en) Treatment
GB9215903D0 (en) Treatment